The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

Sanofi plans to invest around US$1.05 billion to build a new insulin production base in Beijing, which will mark the French ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid ...

French pharma major Sanofi has added a new plant in Singapore to make vaccines and other medicines, as the company seeks to ...

Clinical trials for a revolutionary vaccine to treat acne will be conducted by the National Skin Centre in partnership with ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Sanofi inaugurated its $800m healthcare manufacturing facility, Modulus, located in Tuas Biomedical Park to be operational in ...

The collaboration includes a phase 1 clinical study to start in the second quarter of 2025. The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) ...

Singapore's and Saudi Arabia's health officials have signed a memorandum of understanding to strengthen health sector ...

The home health hub market, valued at $0.80b in 2023, is expected to grow to $9.16b by 2032, with a compound annual growth ...